ARBUCKLE STUART A (EVP\Chief Commercial Officer) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 2/26/2025ACC: 0000875320-25-000105
Officer· EVP\Chief Commercial Officer
Since Jun 2018
-4.72K
Net shares
Net seller
$2.28M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.72K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.72K
Price / share
$483.28
Trade value
$2.28M
% of position
6.3%
2/24/2025
74.72K→70.01K
Total
Net shares
−4.72K
Net value
-$2.28M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | F · Tax Withholding | −4.72K | $483.28 | $2.28M | 6.3% | 74.72K | 70.01K |
| Total | −4.72K | -$2.28M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned140.00
Total
140.00 indirect140.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 140.00 | Indirect |
| Total | 140.00 | 140.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported